Indian Court Rejects Zeria Pharmaceuticals’ Patent Application Over ‘Evergreening’ Concerns

In a significant verdict reinforcing India’s pro-access approach to pharmaceuticals, a local patent court has rejected a patent application filed by Japan-based Zeria Pharmaceutical Co. The application was denied on the grounds of “evergreening,” a controversial practice where pharmaceutical companies attempt to extend patent protection through minor, non-therapeutic modifications to existing drugs.

Zeria, a well-known player in the global pharmaceutical industry, had sought patent rights in India for a revised formulation of an already marketed drug. However, the court ruled that the new version did not demonstrate a significant enhancement in therapeutic efficacy and therefore did not qualify for patent protection under Indian law.

What Is Evergreening?
Evergreening is a tactic used by some pharmaceutical companies to maintain market exclusivity beyond the original patent term. This is typically done by making minor changes to a drug’s formulation, dosage, or delivery method—without a corresponding improvement in medical effectiveness. Such practices can delay the introduction of cost-effective generic versions, which are crucial for public access in low- and middle-income countries.

India’s Patents Act, specifically Section 3(d), was crafted to prevent evergreening by allowing patents for known substances only if the modification leads to enhanced efficacy. This clause has been pivotal in ensuring that patent protection in India is reserved for true innovations, rather than incremental tweaks.

The Court’s Reasoning
In its ruling, the Indian patent office found that Zeria’s revised formulation lacked a demonstrable improvement over the original drug in terms of efficacy. Without substantial scientific evidence supporting a therapeutic benefit, the application fell short of the legal requirements outlined in Section 3(d) of the Patents Act.

The court’s decision echoed the landmark 2013 Supreme Court ruling in the Novartis v. Union of India case, where a similar application was rejected for the cancer drug Glivec. In that ruling, the Supreme Court clarified that the Indian patent regime prioritizes therapeutic advancements over commercial interests.

Industry Reactions and Implications
Health advocacy groups welcomed the verdict, stating that it will help preserve India’s role as a global supplier of affordable medicines. “This decision is a clear message that India’s patent system values real innovation over commercial strategy,” said a spokesperson from a Delhi-based public health NGO.

Meanwhile, industry analysts noted that multinational pharmaceutical companies operating in India may need to revisit their intellectual property strategies. Zeria’s case highlights the risks of relying on reformulated versions of existing drugs to secure long-term market exclusivity in countries with stringent anti-evergreening laws.

Broader Impact on Access to Medicines
India is often referred to as the “pharmacy of the developing world” due to its robust generics industry and relatively strict patent regime. Decisions like this one ensure continued access to affordable medications not only for Indian citizens but also for millions in other countries who depend on Indian generics.

By upholding its legal safeguards against evergreening, India continues to balance the protection of intellectual property with public health needs—a position that has made it both a model and a battleground in global pharmaceutical patent debates.

Conclusion
The rejection of Zeria Pharmaceuticals’ patent application marks another chapter in India’s ongoing effort to promote genuine innovation while preventing the misuse of the patent system. As the global conversation around drug pricing and access intensifies, India’s legal framework remains a critical reference point in the evolving dialogue on intellectual property and public health.

RENA Technologies to Pursue Legal Action Over Patent Infringement in U.S. and India

German solar equipment manufacturer RENA Technologies GmbH has announced plans to initiate legal proceedings in the United States and India against what it describes as unauthorized use of its patented water cap technology. The infringement, according to the company, stems from certain unnamed Chinese equipment suppliers involved in the production and sale of machines used in solar cell manufacturing.

The contested technology—central to RENA’s Function Layer (RFL) process—is covered under patent EP 2 491 584 B1. It enables single-sided etching in solar cell production by protecting the upper side of a wafer with a controlled water cap or liquid film, allowing precise chemical treatment on only one surface. This approach has become an industry standard in advanced solar cell designs, particularly in Passivated Emitter and Rear Cell (PERC) and Tunnel Oxide Passivated Contact (TOPCon) technologies.

Allegations of Widespread Unauthorized Use
RENA Technologies claims to have gathered evidence showing that certain manufacturers are building and promoting etching equipment that utilizes this patented process without proper licensing. While RENA has not disclosed the names of the offending companies, it confirmed that infringements were detected in both U.S. and Indian markets, where solar cell production has expanded significantly in recent years.

“We have invested considerable resources over the past decade to develop and refine the RFL technology,” a spokesperson from RENA said. “Unauthorized replication of our patented process not only undermines our intellectual property but also compromises the principles of fair competition within the solar manufacturing industry.”

Global Footprint and Industry Relevance
Over 630 machines featuring RENA’s RFL technology have been deployed globally, reinforcing the widespread adoption and commercial value of the innovation. The company has highlighted that the patented water cap method is now a critical enabler in high-efficiency solar cell manufacturing, particularly as the industry transitions from PERC to more advanced TOPCon architectures.

The technology’s impact extends beyond performance. By allowing single-side chemical processing without physical contact or damage to the solar wafer, it improves production yield, reduces contamination, and lowers overall manufacturing costs.

Legal and Industry Context
The solar sector has seen a notable rise in patent-related disputes as competition intensifies, especially around next-generation technologies. Several leading Chinese solar manufacturers, including Trina Solar and JA Solar, have recently filed lawsuits in Europe and the U.S. over intellectual property linked to TOPCon advancements.

RENA’s legal initiative reflects a broader trend within the solar industry to safeguard innovation amid increasing global demand for cleaner energy and more efficient photovoltaic solutions.

Legal experts note that the outcome of this case could set a precedent for cross-border IP enforcement in the renewable energy space, especially between European and Asian players. With growing investments in solar infrastructure in India and North America, ensuring robust IP protections is seen as essential to encourage research and attract global partnerships.

Looking Ahead
RENA Technologies’ move to protect its patented water cap system sends a strong signal to the global solar industry about the value of innovation and the importance of enforcing intellectual property rights. As the case unfolds, stakeholders across the manufacturing and legal sectors will be watching closely to see how courts in the U.S. and India respond to these claims.

If successful, the legal action could lead to stricter enforcement of patent licensing in the rapidly evolving solar equipment market and reinforce the importance of respecting proprietary technologies in sustainable energy development.

IIT Kharagpur Alumnus Anil Agiwal Emerges as a Leading Innovator in Wireless Communication

Anil Agiwal, an alumnus of the prestigious Indian Institute of Technology (IIT) Kharagpur, has risen to prominence as one of India’s most prolific inventors in the field of wireless communication technology. His groundbreaking work has earned him a place among the top 50 Indian innovators driving the country’s patent landscape, with over 2,000 patents filed in India and 471 in the United States.

Agiwal, who earned his M.Tech in Computer Science and Information Technology from IIT Kharagpur in 2001, began his career at Samsung R&D Institute in Bangalore in 2002. This early association with cutting-edge research laid the foundation for a career marked by relentless innovation in mobile and wireless communication.

Currently serving as a director at Samsung Research in Seoul, South Korea, Agiwal plays a key role in shaping the future of wireless networks. His expertise spans multiple generations of cellular technology, including 4G, 5G, and the emerging 5G Advanced systems. His work focuses on enhancing mobile broadband capabilities, enabling ultra-reliable low-latency communications, and supporting massive machine-type communications critical to the Internet of Things (IoT).

Agiwal’s contributions have not gone unnoticed. In 2021, he was inducted into an elite group of international inventors recognized for securing more than 200 U.S. patents — a rare achievement that underlines the global impact of his innovations.

Experts in the field highlight the significance of such contributions. According to Ajit Manocha, CEO of global semiconductor industry association SEMI, patents are critical to fostering innovation and ensuring industry leadership. However, others like Satya Gupta, President of the VLSI Society of India, caution that while the volume of patent filings is encouraging, ensuring the quality and practical impact of those patents is equally important.

Despite these concerns, Agiwal’s consistent record of meaningful and high-impact innovations stands out. His achievements underscore the importance of a robust intellectual property framework and highlight India’s growing footprint in the global technology ecosystem.

As India continues its push toward becoming a hub for cutting-edge research and innovation, individuals like Anil Agiwal serve as inspiring examples of what can be achieved through dedication, expertise, and an unwavering focus on progress.

Ducati’s Semi-Automatic Transmission Patent Leaked: A Revolutionary Step in Performance Motorcycling

In a significant technological leap for performance motorcycling, Italian motorcycle manufacturer Ducati is reportedly developing a semi-automatic clutch system, as revealed through a recently leaked patent. The new system aims to blend traditional manual clutch controls with cutting-edge automation, signaling a potential game-changer for both racing and high-performance road bikes.

Dual-Mode Clutch System Offers Versatility

According to the patent, Ducati is working on two variations of the semi-automatic transmission system. Both configurations are designed around a central principle: giving riders the flexibility to either manually operate the clutch or allow the bike’s onboard electronics to handle engagement automatically.

The first system maintains the physical clutch lever and master cylinder, allowing for standard manual control. However, it also integrates an electric motor connected to a hydraulic actuator. When the rider chooses not to use the clutch lever, the motor takes over, engaging or disengaging the clutch based on input from the vehicle’s control unit.

The second system takes a more digital approach. Here, the clutch lever does not control the clutch hydraulically but acts as an input device that sends electronic signals to the ECU (Engine Control Unit). The system then uses an electric motor and actuator to manage clutch operation, potentially enabling a fully automated clutch experience.

Both designs incorporate sensors on the gear shifter to detect rider input, allowing the system to engage the clutch at precise moments. The technology is also capable of integrating engine rev-matching, particularly useful during aggressive downshifting, similar to the “auto-blip” features found on modern superbikes.

Targeted for Racing and High-Performance Applications

Ducati has clearly outlined that the new semi-automatic system is intended for racing and performance motorcycles. The patent mentions compatibility with World Superbike (WSBK) and World Supersport (WSSP) regulations, which do not currently allow the use of seamless gearboxes like those in MotoGP. By introducing a semi-automatic clutch instead, Ducati aims to extract quicker lap times without violating homologation rules.

Interestingly, this suggests that the semi-automatic clutch may first appear on road-legal versions of Ducati’s superbikes, such as the Panigale V4, before being implemented in race-prepped machines. The system also offers functionality for assisted launches, a critical advantage in competitive racing, by automatically modulating clutch engagement to maximize grip and acceleration.

Ducati Joins a Growing Trend

While Ducati is not the first manufacturer to explore semi-automatic transmissions—Honda’s Dual Clutch Transmission (DCT) and Yamaha’s electronic quick-shifters are well-known—their focus remains distinctly on the racing and high-performance segments. Other manufacturers, including KTM and BMW, have also been exploring similar technologies, but Ducati’s approach appears to prioritize mechanical sophistication without compromising rider feel and control.

Unlike fully automatic or CVT systems, Ducati’s semi-automatic clutch retains the soul of manual riding while reducing the physical demands on the rider during high-stress conditions like racing or long-distance touring.

Future Production and Implementation

Although no official timeline has been disclosed, it is expected that Ducati may debut this technology on the next-generation Panigale or potentially a limited-edition performance model. From there, the system could gradually extend to other motorcycles in the Ducati lineup, including adventure or touring bikes such as the Multistrada and Diavel series.

If successful, this move could redefine the standard for performance motorcycles by offering riders the adaptability of manual shifting with the ease of automation—striking a perfect balance between human control and machine intelligence.

Conclusion

Ducati’s leaked patent showcases the brand’s forward-thinking vision and commitment to blending traditional motorcycle dynamics with next-gen technology. The proposed semi-automatic clutch system reflects a step toward making performance motorcycles faster, smarter, and more rider-friendly, without compromising on thrill and engagement. As the world watches closely, Ducati may be gearing up to lead a new era in motorcycle innovation.

Indian-Origin Autistic Teen and Father File US Patent for Inclusive AI-Powered Invention

In a compelling story of innovation, inclusion, and perseverance, a 15-year-old Indian-origin autistic teenager from Dubai has co-filed a U.S. patent for a revolutionary AI-powered invention aimed at addressing global challenges through inclusive design. The young innovator, Zayne Sodawaterwala, teamed up with his father, Merzi Sodawaterwala, to create what they call a “universal human invention” that combines cutting-edge technology with a vision of accessibility and sustainability.

AI-Driven Solution for All Abilities

Filed with the United States Patent and Trademark Office (USPTO) on June 11, 2025, the invention brings together intelligent mobility solutions, regenerative wearable devices, multi-sensory adaptive learning tools, immersive experiences, and eco-conscious design principles. The integrated system is tailored to support people across a wide range of cognitive and physical abilities, especially the neurodiverse and underserved populations.

According to Merzi Sodawaterwala, the invention is “a generational blueprint for an equitable, connected and resilient world,” with potential applications in education, health, urban planning, and social innovation.

Record-Breaking Teen Redefines Autism

Zayne Sodawaterwala, diagnosed as autistic, is no stranger to remarkable achievements. Earlier this year, he broke the Guinness World Record for the fastest 10 km inline skate by a teenager with a time of 40 minutes and 4 seconds, achieved on Dubai’s Al Qudra Track. He followed that up with a 42.55 km marathon skate at the Yas Marina F1 Circuit in Abu Dhabi, completed in just over four hours.

These feats not only earned him recognition from the Special Olympics UAE but also made him the youngest and first neurodivergent world record holder in this category. His determination, self-discipline, and emotional control defy traditional stereotypes about autism.

“Zayne’s journey is an example of how neurodivergent individuals are capable of remarkable self-led transformation,” said his father. “He’s living proof that autism can be a source of strength, not limitation.”

Global Relevance and Societal Impact

The invention, currently under review by the USPTO, is envisioned as a versatile platform capable of improving quality of life across sectors. With AI at its core, the device is designed to personalize experiences for users while supporting inclusive, community-driven growth. It emphasizes real-time feedback, sustainability, and emotional engagement—principles considered essential for next-generation smart environments.

The Sodawaterwalas believe that their innovation can play a pivotal role in creating accessible educational tools, enhancing mental health care, designing future-ready cities, and even addressing climate challenges.

A Vision Beyond Innovation

This patent application is more than a technological achievement; it represents a statement about human potential, inclusion, and the power of family-driven creativity. It challenges global norms around ability, equity, and innovation, setting a powerful precedent for neurodiverse leadership in STEM.

As the world awaits the USPTO’s decision, one thing is clear: the Sodawaterwalas have sparked a global conversation around the role of neurodiversity in shaping a smarter, more compassionate future.

Nike-New Balance Patent Lawsuit Paused Amid PTAB Review, Judge Rules

A federal judge has paused a high-stakes patent dispute between global sportswear giants Nike Inc. and New Balance Athletics, Inc., granting a temporary stay in litigation as the U.S. Patent Trial and Appeal Board (PTAB) reviews several of Nike’s Flyknit patents at the heart of the case.

On June 6, U.S. District Judge Julia E. Kobick ruled in favor of New Balance’s motion to stay the case until August 9, 2025, aligning with the expected PTAB decisions. Nike alleges that New Balance infringed on nine of its Flyknit patents across 61 different shoe models, claiming that the Boston-based company copied its innovative, lightweight knit sneaker technology.

New Balance requested the pause, citing that the PTAB is already actively reviewing six of the nine contested patents. The company argued that a stay would promote judicial efficiency and possibly narrow or eliminate the need for trial if some patents are invalidated.

Judge Kobick, in her ruling, agreed with New Balance’s position, stating that continuing the case while the PTAB deliberates could lead to duplicative proceedings. “Nike has not shown that it will suffer undue prejudice beyond the delay,” Kobick noted, indicating that a short pause would not cause significant harm to the plaintiff.

The judge also highlighted New Balance’s commitment to continue discovery during the stay, including the collection of documents and depositions from international partners. This assurance helped alleviate concerns about lost evidence or unavailable witnesses during the delay.

Nike’s Flyknit technology, first introduced in 2012, is considered a major breakthrough in performance footwear design. The company holds several patents on the material structure, stitching techniques, and manufacturing methods used to create a sock-like fit with minimal waste. Nike contends that New Balance’s knit-based designs unlawfully mirror its patented Flyknit technology.

If the PTAB invalidates some or all of the Flyknit patents under review, it could significantly alter the direction of the case, weakening Nike’s claims and reducing the number of infringing products. Conversely, if the patents are upheld, New Balance may face greater legal exposure and could be required to stop sales or negotiate licensing terms.

The litigation pause is temporary, with proceedings expected to resume following the PTAB’s decisions in August. The outcome will be closely watched by the industry, as it may set a precedent for how similar intellectual property disputes are handled between major athletic brands.

For now, both companies await the PTAB’s judgment, which could either simplify the lawsuit—or set the stage for a prolonged legal battle over innovation in athletic footwear.

Acadia Pharmaceuticals Clinches Patent Victory for NUPLAZID Composition

Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) secured a critical legal win on Tuesday after the U.S. Court of Appeals for the Federal Circuit upheld the validity of the company’s composition of matter patent for its flagship drug, NUPLAZID (pimavanserin). The decision preserves Acadia’s exclusive rights under the ’740 patent and delivers a setback to challengers MSN Laboratories Private Ltd. and MSN Pharmaceuticals, Inc.

The court’s affirmation confirms a lower court ruling that had sided with Acadia in its patent dispute, cementing the biotech firm’s control over the proprietary formulation of NUPLAZID, a therapy approved for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.

“This ruling reinforces the strength of our intellectual property portfolio and our commitment to defending the innovation behind NUPLAZID,” said Steve Davis, CEO of Acadia Pharmaceuticals, in a statement following the announcement. “We are pleased that the court has once again validated our patent, enabling us to continue focusing on delivering therapies to patients with unmet medical needs.”

The legal battle stemmed from efforts by MSN Laboratories and its U.S. affiliate to invalidate Acadia’s ’740 patent, which they argued was not novel or sufficiently inventive. The appellate court rejected these arguments, siding with the company and affirming the patent’s enforceability until its expiration.

The timing of the ruling coincides with Acadia’s robust financial performance. Over the last twelve months, the company has reported revenues nearing $1 billion, with a notable 60% gross margin—a figure that highlights operational efficiency and pricing power in the specialty pharmaceutical market. According to InvestingPro, Acadia currently boasts a “GREAT” financial health score, with more than ten positive metrics contributing to its investment outlook.

Legal experts suggest this ruling will deter potential generic competition in the near term, securing continued market exclusivity for Acadia and potentially preserving its revenue stream from NUPLAZID. The drug remains the first and only FDA-approved treatment for Parkinson’s disease psychosis, positioning it as a valuable asset in Acadia’s expanding neuroscience pipeline.

With the legal hurdle now cleared, analysts anticipate that Acadia will intensify its strategic investments in late-stage clinical programs and explore additional therapeutic indications for pimavanserin.

The decision not only strengthens Acadia’s intellectual property rights but also underscores the importance of robust patent protection in the competitive pharmaceutical sector, where market exclusivity often dictates the pace of innovation and return on investment.

About Acadia Pharmaceuticals:
Founded in 1993 and headquartered in San Diego, California, Acadia Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address central nervous system disorders. Its lead product, NUPLAZID, is approved in the U.S. and continues to be studied for multiple neuropsychiatric indications.

Shoolini University Celebrates Fourth Innovation Day, Champions ‘One Student, One Patent’ Vision

Shoolini University, a leading private research-focused institution in India, celebrated the fourth edition of its flagship event, Shoolini Innovation Day, on Tuesday. The annual event, spearheaded by the university’s Intellectual Property Rights Office (SIPRO), served as a vibrant platform to promote innovation, research, and intellectual property creation among students and faculty.

The central theme of this year’s celebration—“One Student, One Patent”—reaffirmed the university’s bold ambition to make intellectual property a defining element of academic excellence. With participation from across disciplines, the event emphasized Shoolini’s growing reputation as a hub of patent-driven research and startup incubation.

A Platform for Innovation and Recognition

The celebration brought together a wide array of stakeholders, including student innovators, faculty researchers, patent attorneys, and industry experts. A series of exhibitions, interactive sessions, and panel discussions highlighted pioneering research projects and patents filed by the university community.

In his opening remarks, Vice-Chancellor Prof. Atul Khosla lauded the students and faculty for their contributions to India’s knowledge economy. “Innovation is not just a buzzword at Shoolini; it is part of our DNA. The ‘One Student, One Patent’ initiative aims to empower every learner to think beyond textbooks and contribute to real-world solutions,” he said.

SIPRO: Driving the IP Ecosystem

The Shoolini Intellectual Property Rights Office (SIPRO) has played a central role in facilitating the university’s rapid rise in patent filings. Through workshops, mentorship, and legal support, SIPRO has enabled students and researchers to navigate the complex terrain of intellectual property rights with confidence.

Over the past year, SIPRO has supported the filing of over 300 patents, spanning diverse areas such as biotechnology, pharmaceuticals, agriculture, environmental engineering, and artificial intelligence. Many of these patents have resulted from undergraduate and postgraduate research, reflecting a democratization of innovation on campus.

Students at the Forefront

A highlight of the event was the felicitation of student inventors whose work has already received patent grants or is in advanced stages of the application process. The stories of these students—ranging from low-cost water purification systems to AI-based medical diagnostics—offered a glimpse into the practical and socially relevant impact of their innovations.

Speaking at the event, Dr. Anuradha Sharma, Director of SIPRO, emphasized the importance of cultivating early IP literacy. “We are building a future where students see themselves as creators and protectors of knowledge. Our goal is to make patent filing as common as submitting a project report,” she stated.

Collaboration and Future Vision

The event also featured a roundtable discussion on the future of innovation in Indian universities, with participation from industry partners, government representatives, and IP professionals. Collaborations with startups, incubators, and technology transfer agencies were discussed as key enablers to take Shoolini’s patented innovations to market.

Concluding the event, Chancellor Prof. P.K. Khosla reiterated the university’s long-term commitment to IP-driven growth. “Innovation is the currency of the future. Our students must not only dream big but also protect and commercialize their ideas. This is how we will contribute to national development and global progress,” he remarked.

Building a Patent-First Academic Culture

As Shoolini University continues to climb national and global innovation rankings, Shoolini Innovation Day stands as a testament to its strategic investment in intellectual property. With the continued momentum of initiatives like “One Student, One Patent,” the university is poised to emerge as a model for academic institutions aspiring to lead in innovation, research, and IP commercialization.

Piyush Goyal Rejects Allegations of IPR Violations, Calls Them ‘Myths’ Without Basis

India’s Union Minister for Commerce and Industry, Piyush Goyal, firmly refuted recent claims of intellectual property rights (IPR) violations during a press interaction in Bern. Speaking to international media while attending high-level trade discussions in Switzerland, Goyal dismissed allegations of trademark, patent, and copyright infringement as “myths” lacking any concrete evidence.

“Show me one instance where we have illegally copied any trademarks, patents, or copyrighted technology. Not one has been presented,” Goyal said, responding to concerns raised by foreign industry lobbies and some international commentators. He emphasized that India is committed to a transparent and rules-based intellectual property ecosystem, and accused certain vested interests of perpetuating outdated stereotypes.

Defending India’s Innovation Landscape

Goyal highlighted that India has made significant strides in strengthening its IPR regime in line with global standards. “India respects innovation and creativity. Our patent laws, copyright enforcement, and trademark regulations are fully TRIPS-compliant,” he asserted, referring to the World Trade Organization’s Agreement on Trade-Related Aspects of Intellectual Property Rights.

The Minister also pointed to India’s growing contributions to global innovation, particularly in sectors such as pharmaceuticals, information technology, and green energy. He underscored India’s role in providing affordable healthcare and technology solutions to the developing world without compromising intellectual property norms.

Countering Protectionist Narratives

Goyal’s remarks come at a time when some developed nations have expressed concerns about alleged misuse of patented technologies and trademarked products by Indian manufacturers. Industry associations from Europe and North America have, in the past, accused Indian firms of reverse-engineering Western products.

In response, Goyal stated that such criticisms often ignore the spirit of open innovation and are rooted in protectionist agendas. “We will not allow unfounded allegations to undermine India’s reputation. We follow due process, encourage licensing arrangements, and promote indigenous R&D,” he added.

Emphasis on Fair Global Trade

The Minister reiterated India’s commitment to fair global trade practices and called on international partners to engage constructively. He also mentioned India’s recent initiatives to streamline patent processing, strengthen copyright adjudication, and enhance awareness among startups and MSMEs regarding intellectual property.

India’s efforts to foster a culture of innovation have been recognized by global indices. The country ranked 40th in the Global Innovation Index 2023, its highest-ever position, marking a steady climb in recent years.

Looking Ahead

As India continues to integrate into global value chains and negotiates trade agreements with partners such as the European Free Trade Association (EFTA), Goyal’s strong defense of India’s IPR framework sends a clear message. It underscores New Delhi’s resolve to challenge what it sees as unfair narratives while promoting a robust and equitable innovation environment.

“Let’s move past assumptions and work towards genuine partnerships,” Goyal concluded, calling on stakeholders to recognize India not just as a manufacturing hub, but as a responsible player in global intellectual property governance.

Kerala University Secures Patent for Eco-Friendly Solar Cell Technology

In a significant stride toward sustainable energy solutions, the University of Kerala has secured a patent for an innovative eco-friendly solar cell technology. This pioneering development stems from a collaborative effort between the University’s Departments of Physics and Botany, working under the aegis of its Translational Research and Innovation Centre (TRIC-KU).

The patented technology represents a new generation of photovoltaic cells that utilize biodegradable, plant-based materials in place of conventional, environmentally hazardous components. According to university officials, this approach not only reduces the ecological footprint of solar panel production but also enhances affordability and efficiency, especially in tropical regions like Kerala.

A Synergistic Research Model

The breakthrough underscores the success of interdisciplinary collaboration. While the Department of Physics focused on the structural and energy conversion aspects of the solar cells, the Department of Botany contributed crucial insights into the biological materials used to replace synthetic polymers and toxic metals typically found in conventional photovoltaic systems.

“This is a proud moment for Kerala University and a testament to what can be achieved when scientific disciplines converge with a shared purpose,” said Dr. R. S. Suresh, Director of TRIC-KU. “Our aim was to create a clean energy solution that aligns with both ecological and economic sustainability, and this patent is a validation of our vision.”

Technology Rooted in Nature

The solar cells developed by the research team incorporate organic dyes extracted from native plant species as photosensitizers, replacing the more commonly used but environmentally detrimental synthetic chemicals. These natural dyes absorb sunlight and initiate the photoelectric conversion process, mimicking the way plants conduct photosynthesis.

Additionally, the researchers have replaced rare and expensive materials like platinum and ruthenium with easily available carbon-based and bio-derived alternatives, further reducing the cost and environmental impact of production.

Towards Commercialization

With the patent now secured, Kerala University is actively exploring partnerships with clean tech companies and government agencies to commercialize the product. Pilot installations are already being planned across select university campuses and rural community centers in the state, in a bid to test scalability and real-world performance.

Dr. Asha Menon, lead researcher from the Department of Botany, emphasized the broader potential of the technology. “This innovation goes beyond academic achievement. It’s a tangible step toward democratizing access to renewable energy, particularly in resource-constrained settings where cost and environmental considerations are paramount.”

Institutional Push for Innovation

This development is the latest in a series of achievements under the University’s Translational Research and Innovation Centre, which was established to bridge the gap between laboratory research and real-world applications. TRIC-KU aims to transform fundamental research into market-ready technologies, with a special focus on sustainability, health, and energy.

Vice Chancellor Dr. Mohan Kumar congratulated the research team and reaffirmed the university’s commitment to fostering innovation. “Securing this patent places Kerala University on the global map of green technology research. It also aligns with India’s broader mission to transition towards cleaner, more sustainable energy systems.”

Looking Ahead

As climate change accelerates and the world turns increasingly toward renewable energy, Kerala University’s eco-friendly solar cell technology offers a beacon of innovation rooted in local knowledge and global relevance. The institution hopes this patent will pave the way for further research into nature-based solutions that blend science, sustainability, and social impact.